surmount-1 tirzepatide weight loss nondiabetic SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes Tirzepatide for the Maintenance of

Conference on Retroviruses and Opportunistic Infections, Denver, abstract 115, 2026.

A low-normal free triiodothyronine level is associated with adverse prognosis in euthyroid patients with heart failure receiving cardiac resynchronization therapy

These insights can guide whether long-term lower-dose therapy, a dual-compound option like GLP-Squared, or microdose protocols align better with your metabolic genetics

Semaglutide is not a cure for MS, but understanding its potential benefits might offer new options for managing the condition alongside other therapies

Julien Dellinger, Institut de Gnomique Fonctionnelle de Lyon, cole Normale Suprieure de Lyon, CNRS UMR 5242, UCBL Lyon-1 Lyon F-69007, France

Their research suggests the compound might be a safe alternative peptidomimetic to monoclonal anti-alpha4 integrin antibodies, steroids, and other immunosuppressant drugs